Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

PDE5A Antikörper (phosphorylated)

PDE5A Reaktivität: Human, Ratte, Maus, Rind (Kuh), Schwein WB, ELISA, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN2750986
  • Target Alle PDE5A Antikörper anzeigen
    PDE5A (phosphodiesterase 5A, cGMP-Specific (PDE5A))
    Bindungsspezifität
    • 6
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    AA 120-170, phosphorylated
    Reaktivität
    • 25
    • 8
    • 6
    • 4
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Human, Ratte, Maus, Rind (Kuh), Schwein
    Wirt
    • 21
    • 3
    • 1
    Kaninchen
    Klonalität
    • 23
    • 2
    Polyklonal
    Konjugat
    • 15
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser PDE5A Antikörper ist unkonjugiert
    Applikation
    • 18
    • 12
    • 8
    • 7
    • 7
    • 5
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA, Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
    Aufreinigung
    Affinity Purified
    Immunogen
    Phosphorylated synthetic peptide common to all PDE5A variants taken within amino acid region 120-170 on human PDE5A protein.
    Isotyp
    IgG
    Top Product
    Discover our top product PDE5A Primärantikörper
  • Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    1.0-1.25 μg/μL
  • Rajagopal, Nalli, Kumar, Bhattacharya, Hu, Mahavadi, Grider, Murthy: "Cytokine-induced S-nitrosylation of soluble guanylyl cyclase and expression of phosphodiesterase 1A contribute to dysfunction of longitudinal smooth muscle relaxation." in: The Journal of pharmacology and experimental therapeutics, Vol. 352, Issue 3, pp. 509-18, (2015) (PubMed).

    Bautista Niño, Durik, Danser, de Vries, Musterd-Bhaggoe, Meima, Kavousi, Ghanbari, Hoeijmakers, ODonnell, Franceschini, Janssen, De Mey, Liu, Shanahan, Franco, Dehghan, Roks: "Phosphodiesterase 1 regulation is a key mechanism in vascular aging." in: Clinical science (London, England : 1979), Vol. 129, Issue 12, pp. 1061-75, (2015) (PubMed).

    Luong, Rey-Perra, Vadivel, Gilmour, Sauve, Koonen, Walker, Todd, Gressens, Kassiri, Nadeem, Morgan, Eaton, Dyck, Archer, Thébaud: "Antenatal sildenafil treatment attenuates pulmonary hypertension in experimental congenital diaphragmatic hernia." in: Circulation, Vol. 123, Issue 19, pp. 2120-31, (2011) (PubMed).

    Monfort, Muñoz, Felipo: "Chronic hyperammonemia in vivo impairs long-term potentiation in hippocampus by altering activation of cyclic GMP-dependent-protein kinase and of phosphodiesterase 5." in: Journal of neurochemistry, Vol. 94, Issue 4, pp. 934-42, (2005) (PubMed).

  • Target
    PDE5A (phosphodiesterase 5A, cGMP-Specific (PDE5A))
    Andere Bezeichnung
    PDE5A (PDE5A Produkte)
    Synonyme
    CGB-PDE antikoerper, CN5A antikoerper, PDE5 antikoerper, PDE5A2 antikoerper, Cgbpde antikoerper, Cn5n antikoerper, Pde5 antikoerper, Pde5a1 antikoerper, PDE5A antikoerper, pde5a antikoerper, cgb-pde antikoerper, cn5a antikoerper, pde5 antikoerper, pde5a1 antikoerper, phosphodiesterase 5A antikoerper, phosphodiesterase 5A, cGMP-specific antikoerper, phosphodiesterase 5A S homeolog antikoerper, phosphodiesterase 5A, cGMP-specific, b antikoerper, PDE5A antikoerper, Pde5a antikoerper, pde5a.S antikoerper, pde5ab antikoerper, pde5a antikoerper
    Pathways
    Regulation of G-Protein Coupled Receptor Protein Signaling
Sie sind hier:
Kundenservice